Global Expression Competent Cells Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Expression Competent Cells Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
The Protein Expression Competent Cell Pack lets you efficiently economically optimize expression by simultaneously testing multiple strains with your gene of interest. The pack includes BL21(DE3) competent cells for nontoxic proteins and BL21(DE3) pLysS competent cells for both toxic and nontoxic proteins.
Expression Competent Cells report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Expression Competent Cells market is projected to reach US$ 746.9 million in 2033, increasing from US$ 382.5 million in 2022, with the CAGR of 10.1% during the period of 2023 to 2033. Demand from Protein Expression and Other are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Expression Competent Cells industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Expression Competent Cells key companies include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. Merck KGaA, Thermo Fisher Scientific, Agilent Technologies are top 3 players and held % share in total in 2022.
Expression Competent Cells can be divided into Chemically Competent Cells and Electrocompetent Cells, etc. Chemically Competent Cells is the mainstream product in the market, accounting for % share globally in 2022.
Expression Competent Cells is widely used in various fields, such as Protein Expression and Other, etc. Protein Expression provides greatest supports to the Expression Competent Cells industry development. In 2022, global % share of Expression Competent Cells went into Protein Expression filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Expression Competent Cells market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Chemically Competent Cells
Electrocompetent Cells
Protein Expression
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Expression Competent Cells market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Expression Competent Cells introduction, etc. Expression Competent Cells Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Expression Competent Cells market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.![](http://localhost/mraccuracy/images/About Report.webp)
Expression Competent Cells report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Expression Competent Cells market is projected to reach US$ 746.9 million in 2033, increasing from US$ 382.5 million in 2022, with the CAGR of 10.1% during the period of 2023 to 2033. Demand from Protein Expression and Other are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Expression Competent Cells industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Expression Competent Cells key companies include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. Merck KGaA, Thermo Fisher Scientific, Agilent Technologies are top 3 players and held % share in total in 2022.
Expression Competent Cells can be divided into Chemically Competent Cells and Electrocompetent Cells, etc. Chemically Competent Cells is the mainstream product in the market, accounting for % share globally in 2022.
Expression Competent Cells is widely used in various fields, such as Protein Expression and Other, etc. Protein Expression provides greatest supports to the Expression Competent Cells industry development. In 2022, global % share of Expression Competent Cells went into Protein Expression filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Expression Competent Cells market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Chemically Competent Cells
Electrocompetent Cells
Segment by Application
Protein Expression
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Expression Competent Cells market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Expression Competent Cells introduction, etc. Expression Competent Cells Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Expression Competent Cells market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
![](http://localhost/mraccuracy/images/About Report.webp)